0001140361-15-008139.txt : 20150220 0001140361-15-008139.hdr.sgml : 20150220 20150220150510 ACCESSION NUMBER: 0001140361-15-008139 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150220 DATE AS OF CHANGE: 20150220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CollabRx, Inc. CENTRAL INDEX KEY: 0000931059 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 680370244 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-202188 FILM NUMBER: 15635268 BUSINESS ADDRESS: STREET 1: 44 MONTGOMERY STREET, SUITE 800 CITY: SAN FRANCISCO STATE: CA ZIP: 94104-4811 BUSINESS PHONE: (415) 248-5350 MAIL ADDRESS: STREET 1: 44 MONTGOMERY STREET, SUITE 800 CITY: SAN FRANCISCO STATE: CA ZIP: 94104-4811 FORMER COMPANY: FORMER CONFORMED NAME: TEGAL CORP /DE/ DATE OF NAME CHANGE: 19950918 RW 1 formrw.htm COLLABRX INC RW 2-20-2015
CollabRx, Inc.
44 Montgomery Street, Suite 800
San Francisco, California


February 20, 2015

VIA EDGAR

Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
 
Re: Withdrawal of CollabRx, Inc.’s Registration Statement on Form S-1 (File No. 333-202188) with Accession No. 0001140361-15-008087

Ladies and Gentlemen:

On behalf of CollabRx, Inc. (the “Company”), the undersigned hereby respectfully requests that the Company’s Registration Statement on Form S-1 (File No. 333-202188), filed on February 20, 2015, including exhibits (the “Registration Statement”), be withdrawn from registration with the Securities and Exchange Commission (the “Commission”) pursuant to Rule 477 of the Securities Act of 1933, as amended.

The Company requests that the Commission consent to the withdrawal of the Registration Statement on the grounds that the S-1 should have been filed as a S-1 MEF.  The Company confirms that no securities were sold in connection with the offering contemplated by the Registration Statement.

Please send copies of the written order granting withdrawal of the Registration Statement to the undersigned at 44 Montgomery Street, Suite 800, San Francisco, California, facsimile number (415) 248-53505, with a copy to the Company’s counsel, Goodwin Procter LLP, 135 Commonwealth Drive, Menlo Park, California 94025, facsimile number (650) 853-1038, Attention: William Davison.

If you have any questions with respect to this matter, please contact William Davison of Goodwin Procter LLP at (650) 752-3114


   
 
Sincerely,
   
 
CollabRx, Inc.
   
 
By:  /s/ Thomas R. Mika
  Name:  Thomas R. Mika
 
Title:  President and Chief Executive Officer